Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures
Author(s) -
Larry A. Allen,
Gregg C. Fonarow,
Li Liang,
Phillip J. Schulte,
Frederick A. Masoudi,
John S. Rumsfeld,
P. Michael Ho,
Zubin J. Eapen,
Adrian F. Hernandez,
Paul A. Heidenreich,
Deepak L. Bhatt,
Eric D. Peterson,
Harlan M. Krumholz
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.014281
Subject(s) - medicine , isosorbide dinitrate , heart failure , medical prescription , guideline , angiotensin converting enzyme , angiotensin receptor blockers , intensive care medicine , emergency medicine , pharmacology , blood pressure , pathology
Guidelines for heart failure (HF) recommend prescription of guideline-directed medical therapy before hospital discharge; some of these therapies are included in publicly reported performance measures. The burden of new medications for individual patients has not been described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom